FDA inspection
Dipharma Francis Srl: FDA inspection ending Sep 13, 2024
FDA inspection 1331718 · Voluntary Action Indicated (VAI) · Mereto Di Tomba
Key facts
| Inspection ID | 1331718 |
|---|---|
| Firm | Dipharma Francis Srl |
| FEI number | 3002806810 |
| City | Mereto Di Tomba |
| Country | Italy |
| Fiscal year | 2024 |
| Inspection end date | Sep 13, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data